HTLV-1 associated myelopathy/tropical spastic paraparesis

How might HTLV-1 associated myelopathy/tropical spastic paraparesis (HAM/TSP) be treated?

Treatment generally aims to control the specific symptoms, as there is no standard treatment available. Interferon alpha may be beneficial over short periods, and some aspects of the disease may be improved with interferon beta. Stiff and spastic muscles may be treated with lioresal or tizanidine, and urinary dysfunction may be treated with oxybutynin. Corticosteroids were reported to slow progression in one case series and reduce neurologic disability in another. However, others have reported no such benefit with corticosteroids and there have been no randomized clinical trials.

Last updated on 05-01-20

Connect with other users with HTLV-1 associated myelopathy/tropical spastic paraparesis on the RareGuru app

Do you have information about a disease, disorder, or syndrome? Want to suggest a symptom?
Please send suggestions to RareGuru!

The RareGuru disease database is regularly updated using data generously provided by GARD, the United States Genetic and Rare Disease Information Center.

People Using the App

Join the RareGuru Community

To connect, share, empower and heal today.

People Using the App